Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Bull Exp Biol Med ; 175(1): 23-26, 2023 May.
Artículo en Inglés | MEDLINE | ID: mdl-37338757

RESUMEN

We studied the possibility of inhibition of histone deacetylases (HDAC) in the nuclear extract of HeLa cells by N1-hydroxy-N4-(pyridin-4-yl)succinamide (compound 1). Compound 1 inhibits HDAC and showed low toxicity for A-172, HepG2, HeLa, MCF-7, and Vero cells. HeLa cells were most sensitive to the compound. Increasing the interval between administration of compound 1 and the chemotherapeutic agent to 8 h led to an increase in the cytotoxic effect of cisplatin (actinomycin D) on HeLa cells. The combination of compound 1 with cisplatin (actinomycin D) reduced the cytotoxic effect of these drugs for non-tumor Vero cells.


Asunto(s)
Antineoplásicos , Cisplatino , Animales , Chlorocebus aethiops , Humanos , Cisplatino/farmacología , Dactinomicina/farmacología , Ácido Succínico , Células HeLa , Células Vero , Antineoplásicos/farmacología , Piridinas/farmacología , Inhibidores de Histona Desacetilasas/farmacología , Línea Celular Tumoral
2.
Bull Exp Biol Med ; 169(2): 249-253, 2020 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-32651830

RESUMEN

We measured the content of ROS and malondialdehyde in cells of in vivo drug-resistant murine P388 leukemia strains. It was found that the strains did not differ by malondialdehyde concentration, but intracellular concentration of ROS in cells of the cyclophosphamide-resistant strain (P388/CP) was higher than in cells of the original (P388) and other studied strains (P388/Rub, P388/cPt). Nuclear localization of the transcription factor Nrf2 in cells of strain P388/CP attested to its constitutive activation. Enhanced relative expression of the GCLM gene was found in all studied drug-resistant strains; the expression of the GSR and GPX1 genes was increased only in cells of the cyclophosphamide-resistant strain. These findings suggest that the mechanism of resistance of strain P388/CP is associated with increased activity of glutathione metabolism that developed as a result of activation of the antioxidant response transcription factor Nrf2 against the background of high intracellular concentration of ROS.


Asunto(s)
Glutatión/metabolismo , Factor 2 Relacionado con NF-E2/metabolismo , Animales , Antioxidantes/metabolismo , Línea Celular Tumoral , Ciclofosfamida/metabolismo , Malondialdehído/metabolismo , Ratones , Oxidación-Reducción , Especies Reactivas de Oxígeno/metabolismo
3.
Bull Exp Biol Med ; 169(1): 169-175, 2020 May.
Artículo en Inglés | MEDLINE | ID: mdl-32504383

RESUMEN

The effect of inhibition of the tumor suppressor p53 on the antioxidant system genes expression under the influence of cytotoxic compounds of the platinum group was studied. It was found that the action of platinum(II) and platinum(IV) complexes induced accumulation of p53 protein with a maximum in 12 h, which was confirmed by an increase in the expression of the P21 gene, the target gene of the p53 protein. It was shown that the action of platinum complexes activated the expression of catalase and superoxide dismutase 2 genes. Suppression of p53 protein functions with specific inhibitor α-piphitrin under the action of platinum complexes reduced the expression of catalase and superoxide dismutase 2 genes and the target gene P21, which attested to the p53-dependent regulation of these genes.


Asunto(s)
Antineoplásicos/farmacología , Antioxidantes/metabolismo , Proteína p53 Supresora de Tumor/fisiología , Apoptosis/efectos de los fármacos , Apoptosis/genética , Catalasa/efectos de los fármacos , Catalasa/genética , Supervivencia Celular/efectos de los fármacos , Supervivencia Celular/genética , Inhibidor p21 de las Quinasas Dependientes de la Ciclina/genética , Enzimas Reparadoras del ADN/genética , Regulación Enzimológica de la Expresión Génica/efectos de los fármacos , Regulación Neoplásica de la Expresión Génica , Humanos , Células MCF-7 , Estrés Oxidativo/efectos de los fármacos , Estrés Oxidativo/genética , Especies Reactivas de Oxígeno/metabolismo , Superóxido Dismutasa/efectos de los fármacos , Superóxido Dismutasa/genética , Proteína p53 Supresora de Tumor/genética
4.
Bull Exp Biol Med ; 167(3): 339-342, 2019 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-31346869

RESUMEN

Activities of superoxide dismutase and catalase and content of reduced glutathione in cells of drug-resistant murine leukemia P388 strains were studied without or after administration of antitumor compounds. In the absence of chemotherapeutic agents, no significant differences in activities of the studied enzymes in cells of the initial strain and strains resistant to cyclophosphamide, cisplatin, and rubomycin were observed. Compounds to which resistance was developed did not significantly affect activity of enzymes in cells of drug-resistant strains, while the use of compounds that were not resistance inductors was accompanied by a significant decrease in enzyme activity in cells resistant to cisplatin and rubomycin. In cells of strains resistant to cisplatin and cyclophosphamide, the content of reduced glutathione significantly differed from that in the initial strain. In addition, the concentration of reduced glutathione in cells of cyclophosphamide-resistant strain considerably decreased upon addition of the drug producing a therapeutic effect. Our findings suggest that the mechanism of resistance of in vivo derived cyclophosphamide resistant cell strain is related to increased level of reduced glutathione and activity of its metabolism.


Asunto(s)
Antineoplásicos/farmacología , Catalasa/metabolismo , Resistencia a Antineoplásicos/fisiología , Glutatión/análisis , Leucemia P388/tratamiento farmacológico , Superóxido Dismutasa/metabolismo , Animales , Antioxidantes/metabolismo , Línea Celular Tumoral , Cisplatino/farmacología , Ciclofosfamida/farmacología , Daunorrubicina/farmacología , Doxorrubicina/farmacología , Ratones , Ratones Endogámicos DBA , Especies Reactivas de Oxígeno/metabolismo
5.
Bull Exp Biol Med ; 166(6): 779-784, 2019 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-31028582

RESUMEN

The cytotoxicity and antioxidant effects of chitosan-(poly)nitoxides of different molecular weights containing a nitroxide radical of the piperidine structure were studied on tumor (HeLa, A172, and HepG2) and normal (Vero) cell lines. The chitosan-(poly)nitroxides exhibited low cytotoxicity. Under conditions of oxidative stress induced with tert-butyl hydroperoxide, the most pronounced decrease in ROS levels in the presence of chitosan-(poly)nitroxides was observed in normal cells. In cell homogenates, the decrease in malondialdehyde levels was observed only in the presence of low-molecular-weight chitosan-(poly)nitroxide irrespective of the cell line. Our data demonstrate that the cell-specific antioxidant properties of chitosan-(poly)nitroxides are related to their penetration into cells and interaction with intracellular membranes.


Asunto(s)
Antioxidantes/farmacología , Quitosano/farmacología , Óxidos de Nitrógeno/química , Estrés Oxidativo/efectos de los fármacos , Piperidinas/farmacología , Animales , Antioxidantes/síntesis química , Línea Celular Tumoral , Quitosano/análogos & derivados , Quitosano/síntesis química , Chlorocebus aethiops , Células HeLa , Células Hep G2 , Humanos , Neuroglía/efectos de los fármacos , Neuroglía/metabolismo , Neuroglía/patología , Especificidad de Órganos , Piperidinas/síntesis química , Especies Reactivas de Oxígeno/antagonistas & inhibidores , Especies Reactivas de Oxígeno/metabolismo , Relación Estructura-Actividad , Células Vero , terc-Butilhidroperóxido/antagonistas & inhibidores , terc-Butilhidroperóxido/farmacología
6.
Bull Exp Biol Med ; 161(1): 179-83, 2016 May.
Artículo en Inglés | MEDLINE | ID: mdl-27265137

RESUMEN

We studied the function of the antioxidant system in tumor cell lines MCF-7 and H1299 that differ by the state of tumor suppressor gene p53. Exposure to different classes of cytotoxic compounds induced several types of antioxidant system responses that depend on the type of cell line. The effects of platinum(II) and platinum(IV) complexes on activity of antioxidant enzymes vary, which can be explained by differences in their accumulation and biotransformation in tumor cells. Triazole and oxazolidinone derivatives had little effect on activity of superoxide dismutase and catalase in H1299 cells, but increased superoxide dismutase activity in MCF-7 cells.


Asunto(s)
Antineoplásicos/toxicidad , Catalasa/metabolismo , Cisplatino/toxicidad , Compuestos Organoplatinos/toxicidad , Superóxido Dismutasa/metabolismo , Inducción Enzimática , Humanos , Concentración 50 Inhibidora , Células MCF-7 , Estrés Oxidativo , Especies Reactivas de Oxígeno/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...